CEVA, Inc.
CEVA · NASDAQ
Analyst ratings
strong_buy · 8 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 13, 2026 | TD Cowen | Maintains | Buy | $55.00 |
| July 10, 2026 | Stifel | Maintains | Buy | $50.00 |
| June 15, 2026 | Needham | Initiates Coverage On | Buy | $55.00 |
| May 12, 2026 | UBS | Maintains | Buy | $48.00 |
| May 12, 2026 | Rosenblatt | Maintains | Buy | $45.00 |
| May 12, 2026 | Oppenheimer | Maintains | Outperform | $42.00 |
| May 12, 2026 | TD Cowen | Maintains | Buy | $45.00 |
| May 12, 2026 | JP Morgan | Maintains | Neutral | $36.00 |
| May 4, 2026 | UBS | Maintains | Buy | $42.00 |
| March 12, 2026 | Rosenblatt | Maintains | Buy | $40.00 |
| February 18, 2026 | Oppenheimer | Reiterates | Outperform | $30.00 |
| February 18, 2026 | Rosenblatt | Maintains | Buy | $40.00 |
| November 12, 2025 | Barclays | Maintains | Overweight | $35.00 |
| November 11, 2025 | Rosenblatt | Maintains | Buy | $40.00 |
AI and edge computing growth potential vs. overvaluation risk
CEVA is well-positioned to capitalize on the proliferation of edge AI, with its NeuPro NPU architectures gaining traction across audio, video, and infrastructure markets. An AI/NPU royalty stream is expected to become meaningful by 2027, and a new AI licensing deal signals accelerating customer adoption that could drive materially higher royalty revenue per device.
Despite the AI-driven excitement, CEVA's share price has surged over 100% in the past year and now trades above estimated fair value, with InvestingPro analysis flagging the stock as potentially overvalued. High R&D spending continues to pressure margins and delays any clear path back to profitability, making the risk/reward for new buyers questionable.
Royalty ramp timeline and licensing model transition
Stifel and other analysts highlight a licensing model shifting toward higher-value, integrated, system-level engagements, with a royalty stream in the early stages of a multi-year Wi-Fi, combo chip, and cellular IoT ramp. UBS noted 18% year-over-year licensing growth, and TD Cowen cited traction in higher-value system-level deals as evidence the transition is gaining momentum.
Stifel itself characterizes 2026 as an 'ongoing transition year,' meaning near-term revenue inflection is deferred to 2027 at the earliest. Benchmark initiated coverage with only a Hold rating, reflecting skepticism that prior licensing wins will convert to meaningful royalties quickly enough to justify current elevated valuation multiples well above the five-year median.
Stock valuation relative to peers and intrinsic value
CEVA's Price-to-Sales ratio of 12.3x compares favorably to the peer average of 13x, suggesting the stock is reasonably valued relative to direct semiconductor IP competitors. Analyst consensus remains strongly positive, with an average 12-month price target of $50, representing nearly 30% upside from recent closing prices.
CEVA trades significantly above SimplyWallSt's estimated future cash flow value of $15.89 and above the estimated fair Price-to-Sales ratio of 10.9x. Compared to the broader US semiconductor industry average P/S of 8.6x, the stock appears expensive, and Stifel's new price target relies on an 8.5x EV/Sales multiple nearly double the company's five-year median of 4.4x.